Skip to main content

Peer Review reports

From: PPARD rs2016520 (T/C) and NOS1AP rs12742393 (A/C) polymorphisms affect therapeutic efficacy of nateglinide in Chinese patients with type 2 diabetes mellitus

Original Submission
14 Jul 2021 Submitted Original manuscript
27 Aug 2021 Reviewed Reviewer Report
20 Sep 2021 Reviewed Reviewer Report - Dhite Nugroho
21 Sep 2021 Author responded Author comments - Qian Lu
Resubmission - Version 2
21 Sep 2021 Submitted Manuscript version 2
4 Oct 2021 Author responded Author comments - Qian Lu
Resubmission - Version 3
4 Oct 2021 Submitted Manuscript version 3
9 Oct 2021 Reviewed Reviewer Report - Dhite Nugroho
17 Oct 2021 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
18 Oct 2021 Editorially accepted
12 Nov 2021 Article published 10.1186/s12920-021-01108-5

You can find further information about peer review here.

Back to article page